NSETrading Window3d ago · 15 Sept 2026, 04:46 pm
Trading Window
AstraZeneca Pharma India Limited · ASTRAZEN
✦ AI SummaryRegulatory
AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will be closed from September 16, 2026, and will reopen after 48 hours from the declaration of Un-audited Financial Results of the Company for the quarter and half year ending September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
ASTRAZEN_15092026164645_Closure_of_trading_window_Sept_2026.pdf
View document text
September 15, 2026
The Manager - Listing
National Stock Exchange of India Ltd.
Exchange Plaza,
Bandra-Kurla Complex, Bandra (E),
Mumbai – 400 051
The Manager - Listing
BSE Limited
P J Towers, Dalal Street, Fort,
Mumbai – 400 001
Dear Sir/ Madam,
Sub: Closure of Trading Window
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of
India (Prohibition of Insider Trading) Regulations, 2015, read with AstraZeneca Pharma India Limited -
Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Equity Shares
of the Company will be closed from September 16, 2026 and the same shall reopen after 48 hours from
the declaration of Un-audited Financial Results of the Company for the quarter and half year ending
September 30, 2026.
We request you to please take the same on record.
Thanking you,
For AstraZeneca Pharma India Limited
Tanya Sanish
Company Secretary & Compliance Officer